HMGA2 gene polymorphisms and Wilms tumor susceptibility in Chinese children: a four-center case-control study.
Wilms tumor is a kidney malignancy that typically occurs in children. Aberrant expression of HMGA2 gene is commonly seen in many malignant tumors. Yet, HMGA2 gene polymorphisms on Wilms tumor risk is not established. We carried out the first four-center case-control study with 355 patients and 1070 controls to assess the association of HMGA2 polymorphisms (rs6581658 A>G, rs8756 A>C, and rs968697 T>C) with Wilms tumor risk. All of these three polymorphisms in single could not impact Wilms tumor risk. Stratified analysis revealed a contributing Wilms tumor risk role of rs968697 TC/CC in subgroup of male [TC/CC vs. TT: adjusted odds ratio (OR) = 1.46, 95% confidence interval (CI) = 1.03-2.08, P = 0.035]. However, we found that presence of 1-3 protective genotypes were less likely to develop tumor in subgroup of female (adjusted OR = 0.69, 95% CI = 0.48-0.99, P = 0.045). Our findings suggest that HMGA2 gene polymorphisms might influence Wilms tumor predisposition in a weak manner, under certain circumstances. The current study represents the first one to explore the relationship between HMGA2 gene polymorphisms and Wilms tumor risk. We firstly demonstrated that rs6581658 A>G, rs8756 A>C, and rs968697 T>C could not impact Wilms tumor risk, respectively. We shed light on the participation of HMGA2 gene polymorphisms in the risk of Wilms tumor, under certain circumstances. This article is protected by copyright. All rights reserved.